Voltar
Artigo Revisado por pares
BIBTEX RIS

A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumors

2010; Springer Science+Business Media; Volume: 30; Issue: 1 Linguagem: Inglês

10.1007/s10637-010-9529-9

ISSN

1573-0646

Autores

Eduardo Vilar, Viktor Grünwald, Patrick Schöffski, Harald Singer, Ramón Salazar, J. L. Mesías Iglesias, Enrique de Álava, Martín Cullell-Young, José Baselga, Josep Tabernero,

Tópico(s)

Endoplasmic Reticulum Stress and Disease

Referência(s)